EBV LMP2A Antikörper
Kurzübersicht für EBV LMP2A Antikörper (ABIN2473474)
Target
Reaktivität
Wirt
Klonalität
Konjugat
Applikation
Klon
-
-
Produktmerkmale
- Purified IgG
-
Aufreinigung
- Purified
-
Immunogen
- Bacterial TrpE-LMP2A fusion protein
-
Isotyp
- IgG1
-
-
-
-
Applikationshinweise
- Optimal working dilution should be determined by the investigator.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Konzentration
- 1.0 mg/mL
-
-
-
: "Epstein-Barr virus latent infection and BAFF expression in B cells in the multiple sclerosis brain: implications for viral persistence and intrathecal B-cell activation." in: Journal of neuropathology and experimental neurology, Vol. 69, Issue 7, pp. 677-93, (2010) (PubMed).
: "Modulation of LMP2A expression by a newly identified Epstein-Barr virus-encoded microRNA miR-BART22." in: Neoplasia (New York, N.Y.), Vol. 11, Issue 11, pp. 1174-84, (2009) (PubMed).
-
-
- EBV LMP2A (Epstein-Barr Virus Latent Membrane Protein 2A (EBV LMP2A))
-
Andere Bezeichnung
- EPSTEIN-BARR VIRUS LMP2A
-
Substanzklasse
- Viral Protein
-
Hintergrund
- Synonyms: EBV
Target
-